Skip to content

Common Stock at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
200M0.0%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$6K0.0%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$67K+1.5%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
390M+30.0%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$8K+14.3%
Alumis Inc. logo
Alumis Inc.ALMS
$1K

Other financials

Income statement

See full
Revenue$900.0K+12.5%
Operating income-$47.9M-80.1%
Net income-$47.6M-75.6%
EPS (diluted)-$0.11+57.7%

Balance sheet

See full
Cash & equivalents$229.2M+1,668%
Total debt$6.1M-15.7%
Total equity$207.9M+7,069%
Total assets$266.4M+427%

Cash flow

See full
Operating cash flow-$49.1M-149%
CapEx$400.0K
Free cash flow-$49.5M-151%

Valuation

See full
Market cap$948.17M+269%
Enterprise value$725.07M+188%
P/S163.9×+91.4×

Profitability

See full
Operating margin-2,910.4%-265pp
Net margin-2,895.4%-257pp
FCF margin-2,619.5%+69.9pp

Returns & leverage

See full
Return on equity-158.9%-26.4pp
Debt / equity-2.5×
Current ratio4.8×+4.0×

Where this comes from

Reported directly by DBV Technologies in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DBV Technologies's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DBV Technologies's common stock?
DBV Technologies (DBVT) reported common stock of $33.96M in Q1 2026.
How has DBV Technologies's common stock changed year-over-year?
DBV Technologies's common stock increased by 191.4% year-over-year, from $11.65M to $33.96M.
What is the long-term trend for DBV Technologies's common stock?
Over 5 years (2020 to 2025), DBV Technologies's common stock has grown at a 32.8% compound annual growth rate (CAGR), from $6.52M to $26.91M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).